OBERBAUER R, HUTCHISON B, ERIS J, ARIAS M, CLAESSON K, MOTA A, KREI...
6.
Oberbauer R, Hutchison B, Eris J, Arias M, Claesson K, Mota A, Kreis
ance. Such strategies would include more support from allH, Kleinman L, Wang F, Chen J, Revicki DA: Health-related qual-
members of a transplant team and also shorter follow-upity-of-life outcomes of sirolimus-treated kidney transplant
intervals as outpatient to check the immunosuppressivepatients after elimination of cyclosporine A: results of a 2-
year randomized clinical trial.
Transplantation 2003,
trough levels more frequently than in compliant patients.